Domains featuring this topic
Explore the domains where this topic appears.
Wellcome Career Development Awards — November 2026 round
Funding for mid-career researchers from any discipline who have the potential to become international research leaders and whose work relates to human life, health and wellbeing.
Wellcome Early-Career Awards — November 2026 round
Funding for early-career researchers from any discipline who are ready to develop their research identity through an innovative project related to human life, health and wellbeing.
NSF SBIR/STTR Pilot Emphasis on Scientific Instrumentation
NSF funding for startups and small businesses developing next-generation scientific instruments, experimental platforms and enabling technologies for research.
NSF SBIR/STTR: Developing Deep Technologies
NSF SBIR and STTR funding for startups and small businesses transforming high-risk technologies into products and services with commercial and societal impact.
ERC Starting Grant
ERC-2027-STG call, opened 22 July 2026. Supports early-career researchers of any nationality to build their own teams and pursue frontier research in any field, with grants of up to EUR 1.5 million for 5 years (additional funding possible for relocation or major costs).
UKRI Translation: BBSRC Proof of Concept 2026
Funding to translate bioscience research into innovations such as products, services and solutions with real-world economic, societal and environmental impact. Opened 5 August 2026; £3,000,000 total, £100,000–£800,000 per project at 80% full economic cost.
Wellcome Discovery Awards
Funding for established researchers and teams from any discipline to pursue bold, creative research that can deliver significant shifts in understanding related to human life, health and wellbeing.
ERC Proof of Concept Grant
ERC-2026-PoC call funding ERC grantees to explore the innovation potential of their frontier research; a lump sum of EUR 150,000 for a period of 18 months, with one application per Principal Investigator per call.
NIH Director's Pioneer Award (DP1 Clinical Trial Optional)
RFA-RM-27-001, posted June 29, 2026 and currently open. The Pioneer Award supports individual scientists proposing pioneering, high-impact approaches to major challenges in biomedical or behavioral research; 8 awards expected from $8,000,000 in program funding.
ERC Plus Grant 2026
The ERC Plus Grant supports a single principal investigator pursuing an ambitious, transformative frontier-research project beyond the scope of existing ERC grants, with four to seven years of lump-sum funding.
ERC Advanced Grant
ERC-2026-ADG call, opened 28 May 2026. For established researchers with a track-record of significant research achievements, in any scientific field, hosted in an EU Member State or associated country; up to EUR 2.5 million for 5 years, with additional funding possible.
A Toolkit to Succeed in Neuroscience in Africa - an IBRO-ALBA-WWN-SANS Webinar
Following up on last year's webinar - What it takes to succeed as a neuroscientist in Africa, this panel discussion aims at creating a guide to the skill set needed to be a neuroscientist in the African continent. Chairs and panelists will illustrate different areas of expertise as part of the "Toolkit" by matching them to real life experience and solutions that they had to find while building their career as scientists.
Root causes and possible solutions to academic bullying in higher education
Academic bullying is a serious issue that affects all disciplines and people of all levels of experience. To create a truly safe, productive, and vibrant environment in academia requires coordinated and collaborative input as well as the action of a variety of stakeholders, including scholarly communities, funding agencies, and institutions. This talk will focus on a framework of integrated responding, in which stakeholders as responsible and response-able parties could proactively collaborate and coordinate to reduce the incidence and consequences of academic bullying while at the same time building constructive academic cultures. The outcome of such a framework would be to create novel entities and actions that accelerate successful responses to academic bullying.
ALBA-WWN Webinar: What it takes to succeed as a neuroscientist in Africa
In this webinar, the ALBA Network & World Women in Neuroscience partner to address equity, inclusion & diversity issues across the Sub-Saharan African neuroscience community. The panel discussion will explore the challenges and biases faced by African neuroscientists while establishing their careers - focusing on a lack of mentoring and networking but also on the difficulties to raise funding - as well as display the strengths present in the region, which can be exploited to find solutions. Registration is free but required: https://www.alba.network/alba-wwn-webinar-africa
From bench to clinic – Translating fundamental neuroscience into real-life healthcare practices, and developing nationally recognised life science companies
Dr. Ryan C.N. D’Arcy is a Canadian neuroscientist, researcher, innovator and entrepreneur. Dr. D'Arcy co-founded HealthTech Connex Inc. and serves as President and Chief Scientific Officer. HealthTech Connex translates neuroscience advances into health technology breakthroughs. D'Arcy is most known for coining the term "brain vital signs" and for leading the research and development of the brain vital signs framework. Dr. D’Arcy also holds a BC Leadership Chair in Medical Technology, is a full Professor at Simon Fraser University, and a member of the DM Centre for Brain Health at the University of British Columbia. He has published more than 260 academic works, attracted more than $85 Million CAD in competitive research and innovation funding, and been recognized through numerous awards and distinctions. Please join us for an exciting virtual talk with Dr. D'Arcy who will speak on some of the current research he is involved in, how he is translating this research into real-life applications, and the development of HealthTech Connects Inc.
Identification and treatment of advanced, rupture-prone plaques to reduce cardiovascular mortality
Atherosclerosis is the underlying cause of major cardiovascular events, including heart attack and stroke. The build-up of plaque in coronary arteries can be a major risk for events, but risk is significantly higher in patients with vulnerable rather than stable plaque. Diagnostic imaging of vulnerable plaque is extremely useful for both stratifying patient risk and for determining effectiveness of experimental intervention in reducing cardiovascular risk. In the preclinical setting, being able to distinguish between stable and vulnerable plaque development and pair this with biochemical measures is critical for identification of new experimental candidates. In this webinar, Professor Stephen Nicholls and Dr Kristen Bubb from the Victorian Heart Institute will discuss the benefits of being able to visualise vulnerable plaque for both clinical and preclinical research. Professor Stephen Nicholls is a clinician-researcher and the Head of the Victorian Heart Institute. He is the lead investigator on multiple large, international, cardiovascular outcomes trials. He has attracted over $100 million in direct research funding and published more than 400 peer-reviewed manuscripts. He is focused on both therapeutic intervention to reduce vascular inflammation and lipid accumulation and precision medicine approaches to prevent cardiovascular mortality. Dr Kristen Bubb is a biomedical researcher and Group Leader within the Monash Biomedicine Discovery Institute Cardiovascular Program and Victorian Heart Institute. She focuses on preclinical/translational research into mechanisms underlying vascular pathologies including atherosclerosis and endothelium-driven hypertension within specific vascular systems, including pulmonary and pregnancy-induced. She has published >30 high impact papers in leading cardiovascular journals and attracted category 1&2 funding of >$750,000.
How to turn a Machine Learning Use Case into a Successful Startup
Have a great idea involving AI? Want to launch your own business? It takes many iterations before an idea becomes a startup. Lots of coffee, heartache, and git reverts fuel these iterations. We have learned a lot from Cape AI's own incubated startup, Moonshop, Africa's first autonomous microstore. Watch the demo here: https://www.youtube.com/watch?v=odX6kxhLFC4 Attend our virtual roadshow event to hear lightning talks on creating proofs of concept, failing fast, funding models, selecting and growing a team, finding customers/clients, and building your brand. Afterwards, there will be a short break, then a panel discussion where members of the Cape AI team will answer questions from the audience.
Neural mechanisms of active vision in the marmoset monkey
Human vision relies on rapid eye movements (saccades) 2-3 times every second to bring peripheral targets to central foveal vision for high resolution inspection. This rapid sampling of the world defines the perception-action cycle of natural vision and profoundly impacts our perception. Marmosets have similar visual processing and eye movements as humans, including a fovea that supports high-acuity central vision. Here, I present a novel approach developed in my laboratory for investigating the neural mechanisms of visual processing using naturalistic free viewing and simple target foraging paradigms. First, we establish that it is possible to map receptive fields in the marmoset with high precision in visual areas V1 and MT without constraints on fixation of the eyes. Instead, we use an off-line correction for eye position during foraging combined with high resolution eye tracking. This approach allows us to simultaneously map receptive fields, even at the precision of foveal V1 neurons, while also assessing the impact of eye movements on the visual information encoded. We find that the visual information encoded by neurons varies dramatically across the saccade to fixation cycle, with most information localized to brief post-saccadic transients. In a second study we examined if target selection prior to saccades can predictively influence how foveal visual information is subsequently processed in post-saccadic transients. Because every saccade brings a target to the fovea for detailed inspection, we hypothesized that predictive mechanisms might prime foveal populations to process the target. Using neural decoding from laminar arrays placed in foveal regions of area MT, we find that the direction of motion for a fixated target can be predictively read out from foveal activity even before its post-saccadic arrival. These findings highlight the dynamic and predictive nature of visual processing during eye movements and the utility of the marmoset as a model of active vision. Funding sources: NIH EY030998 to JM, Life Sciences Fellowship to JY
Investigating the impact of the pandemic on adolescent anxiety and cognitive function
Meg was awarded funding to look into how the coronavirus pandemic has affected children's mental health and wellbeing.
Biomarkers for Addiction Treatment Development: fMRI Drug Cue Reactivity as an Example
This webinar is mainly focused on “Biomarkers for Addiction Treatment Development: fMRI Drug Cue Reactivity as an Example”. Biomarkers and Biotypes of Drug Addiction: funding opportunities at NIDA, Tanya Ramey (NIDA, US) Neuroimaging-based Biomarker Development for Clinical Trials, Owen Carmicheal (Pennington Biomedical Research Center, USA) ENIGMA-Addiction Cue Reactivity Initiative (ACRI) and Checklist, Hamed Ekhtiari (Laureate Institute for Brain Research, USA) ENIGMA-ACRI Checklist: Participant Characteristics, General fMRI Information, General Task Information, Cue Information, Task-related Assessments, Pre-Post Scanning Consideration (James Prisciandaro, Medical University of South Carolina, USA; Marc Kaufman, McLean Hospital/Harvard Medical School, USA; Anna Zilverstand, University of Minnesota; Torsten Wüstenberg, Charité Medical University Berlin, Germany; Falk Kiefer, University of Heidelberg, Germany; Amy Janes, Harvard Medical School, USA) How to Add fMRI Drug Cue Reactivity to the ENIGMA Consortium: Road Ahead, Hugh Garavan, University of Vermont)
African Neuroscience: Current Status and Prospects
Understanding the function and dysfunction of the brain remains one of the key challenges of our time. However, an overwhelming majority of brain research is carried out in the Global North, by a minority of well-funded and intimately interconnected labs. In contrast, with an estimated one neuroscientist per million people in Africa, news about neuroscience research from the Global South remains sparse. Clearly, devising new policies to boost Africa’s neuroscience landscape is imperative. However, the policy must be based on accurate data, which is largely lacking. Such data must reflect the extreme heterogeneity of research outputs across the continent’s 54 countries. We have analysed all of Africa’s Neuroscience output over the past 21 years and uniquely verified the work performed in African laboratories. Our unique dataset allows us to gain accurate and in-depth information on the current state of African Neuroscience research, and to put it into a global context. The key findings from this work and recommendations on how African research might best be supported in the future will be discussed.
Individual Research Grants
DFG's central individual funding programme for research projects in all disciplines: 'The first proposal may be submitted at any time.' Duration is based on individual project needs, as a rule several years, with modules for staff, instrumentation and other project costs.
MRC: research grant: applicant-led
MRC's applicant-led responsive research grant, explicitly 'Open - no closing date': submit when the application is ready. No upper funding limit — the amount should be appropriate to the project — for up to five years, with MRC funding 80% of full economic cost.
Targeted Grants in MPS
Supports high-risk projects of exceptional promise and scientific importance in mathematics and the physical sciences, with funding for up to five years; letters of intent are accepted on a rolling basis and there is no recommended or assumed funding level.
Computer and Information Science and Engineering: Future Computing Research (Future CoRe)
Active NSF solicitation (NSF 25-543) funding core computer and information science and engineering research. Proposals are accepted anytime, with target dates (second Thursday in September and first Thursday in February annually) for panel review cycles; projects up to $1,000,000 and 4 years.